Rights and permissions
About this article
Cite this article
Kroft, S., Tallman, M., Shaw, J. et al. Myelodysplastic following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA). Leukemia 11, 170 (1997). https://doi.org/10.1038/sj.leu.2400523
Received:
Accepted:
Issue Date:
Further reading
-
Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis
International Journal of Hematology (2013)
-
Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma
Cancer (2010)
-
Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases
Molecules (2009)
-
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells
British Journal of Haematology (2009)
-
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
Blood (2005)
